Consecutive immunostaining for YAP/TAZ and a cancer cell marker cytokeratin (CK) AE1/AE3 revealed that CK+ cancer cells exhibited both homogenous and heterogeneous expression patterns of YAP/TAZ within tumor tissues (Fig. 1B). The gene discussed is YAP1; the disease is neoplasm.